thanks to these prices my avg is 8.93. Considering stock was 23 and 200 and 50 day avg, my price is not that high. One minor positive remarks ,and thanks to 21 mil shorts I can be green in no time. Anyone else buying/adding
Your ignorance is astounding. Per your logic no costly medical procedures are allowed since insurance won't want to cover. When all else fails K will be prescribed -- accept that. Let's take another example -- If a patient has heart issues and goes from bad to worse at some point a transplant might be recommended. Is that costly? Yes! Will insurance cover it? Yes, if it's part of the policy.
You and your multiple ID's seem "challenged". Everyone here knows K is for TREATMENT FAILURE GOUT patients. Yes, it is the last option. And insurance will pay more than the 10% you cite.
Your continued grudge and axe to grind show you to be an angry person who apparently feels wronged in some way. Grow up. Life goes on. Let go of the animosity. No one here is impressed with your continued rants.
OTher than one bcbs site no other managed care requires uloric . Allup and uloric are in same therapeutic class. Yes drug price may create some issues, but doctor job to prescribe the best drug for the patient and not the cheapest drug.
It is insurance job to push you for cheap drugs. For example for most aetna plans if high dose allup has not shown improvements then aetna IS more than happy to go with krystexxa.
same with VA and Medicare
Check all those links harness and others posted.
These volatile biotechs subject to halving and doubling quickly are difficult to time. I think I only managed to averaging down on DNDN into the 6's despite it going below $3 briefly.
Tough watching others catch a perfect bottom, but most of them are liars. Averaging down when your DD tells you it's way undervalued while others are selling no matter what is still going to pay off for you.
I would not be surprised if SVNT trades over $20 in 2012
I have added more here as well. This is turning out to be a long term play. EU, Asia and US sales will in the 400 million range by 2014. You can take that to the bank. I have seen this drug in action. It is no joke; it works. IT IS NOT a GOUT treatment, but reverses DISABILITIES caused by treatment refractory gout which costs millions to treat via hospitalizations, drugs that won't work, etc.
doubtful, The pps fall is due to the market right now. Traders are running from risk. SO what. If I cared everytime I was called a bagholder I would have missed all of the upswing in 2009. I was a bag in JPM at 20 and GNW at 3 blablabla..... Time will sort this all out. The drug works, and its approved. Worse case they firesale the co. in the low teens but I dont think that happens.
No, I have my position and I am sticking with it. The price action is too weak to add right now. If it goes to 6 Ill add via calls, but I have been buying puts and hedging and making money on the downside while holding my long pos. I have also been selling covered calls to lower my cost average. But I wont buy more shares right now.